With the lifting of two moratoria on genetically modified crops in Australia recently, so did the inevitably polarised debate take off. Those for and against are unlikely to change their minds and, unfortunately, some scientists are now afraid to speak theirs.

Victorian biotech and life science companies are invited to apply for the next round of the Vistech program.

A US$6 million fund was launched today for joint Israeli-Victorian projects in areas such as biotechnology, healthcare, nanotechnology, environmental technologies and advanced manufacturing.

The Lorne Conference on Protein Structure and Function is celebrating its 30th anniversary this year. Graeme O'Neill discovers why there's plenty to celebrate.

Following a call by the European Commission for increased technology research, Microsoft has launched an initiative to invest in scientific research centres in Europe.

The Australian Capital Territory, home to CSIRO's Plant Industry division, looks set to join the southern mainland states and Tasmania in imposing a moratorium on the environmental release of genetically modified crops.

Compumedics CEO David Burton has received an Entrepreneur of the Year award from global accounting firm Ernst and Young.

Prof Alan Trounson is stepping away from his role as CEO of the National Stem Cell Centre (NSCC) to become its Global Science Strategic Advisor, with a focus on expanding the centre's international relationships and influence.

With a nationwide freeze in place on commercial production of genetically modified canola, Australia's leading plant geneticist delivered a warning to GM-shy state governments yesterday: use it, or lose markets.

Analysts and industry experts are widely predicting biotechnology and life sciences to be strong growth areas this year, but in comparison to other Asian markets, Hong Kong seems off the pace.